C. Barbara

2.6k citations
32 papers · 1.6k · 1 hit paper · h-index 15

Impact in

  • Hepatology top 2%
    • Hepatocellular Carcinoma Treatment and Prognosis
  • Oncology top 2%
    • Colorectal Cancer Treatments and Studies
    • Cancer Treatment and Pharmacology
    • Pancreatic and Hepatic Oncology Research
    • Colorectal Cancer Surgical Treatments

Papers in

    • Colorectal Cancer Treatments and Studies 20
    • Cancer Treatment and Pharmacology 8
    • Cancer Immunotherapy and Biomarkers 3
    • Colorectal Cancer Surgical Treatments 3
    • Lung Cancer Treatments and Mutations 6
    • Gastric Cancer Management and Outcomes 2

C. Barbara

32 papers receiving 1.5k citations

C. Barbara's Hit Papers

Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest 2007 · 906 citations
9060+6+12Years since publication250500750

Peers

C. Barbara
Comparison fields: 5 of 79
  • Hepatology 400
  • Oncology 1.0k
  • Pulmonary and Respiratory Medicine 296
  • Pathology and Forensic Medicine 139
  • Cancer Research 99
Replace G Brufman with:
G Brufman Israel
G. Gruia France
Jenny F. Seligmann United Kingdom
W P Tong United States
Lucille Leong United States
Kenneth C. Micetich United States
Martha M. Kirstein Germany
Kenjiro Kotake Japan
Angela Meade United Kingdom
Gennaro Gadaleta‐Caldarola Italy
C. Barbara relative to G Brufman Israel G Brufman's profile →
Citations per field
00.5×2×3×3.5×
G Brufman · 1×
Citations per year

Countries citing papers authored by C. Barbara

Since Specialization
Citations

This map shows the geographic impact of C. Barbara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Barbara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Barbara more than expected).

Fields of papers citing papers by C. Barbara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Barbara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Barbara. The network helps show where C. Barbara may publish in the future.

Co-authors

The 25 scholars most cited alongside C. Barbara, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with C. Barbara Line = papers co-authored together C. Barbara links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Phase III Trial of Infusional Fluorouracil, Leucovorin, Oxaliplatin, and Irinotecan (FOLFOXIRI) Compared With Infusional Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) As First-Line Treatment for Metastatic Colorectal Cancer: The Gruppo Oncologico Nord Ovest
Hit paper breakdown →
2007906
2 2015126
3 199967
4 200662
5 202148
6 201347
7 201643
8 200242
9 201138
10 201733
11 200423
12 200622
13 200617
14 200015
15 201314
16 200114
17 200513
18 20119
19 20218
20 20127

About C. Barbara

C. Barbara is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Molecular Biology, Surgery and Organic Chemistry, having authored 32 papers that have together received 1.6k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (20 papers), Cancer Treatment and Pharmacology (8 papers), Lung Cancer Treatments and Mutations (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Colorectal Cancer Surgical Treatments (3 papers), Cancer therapeutics and mechanisms (2 papers), Gastric Cancer Management and Outcomes (2 papers) and Sinusitis and nasal conditions (1 paper). The work is most often cited by research in Hepatology (400 citations), Oncology (1.0k citations), Pulmonary and Respiratory Medicine (296 citations), Pathology and Forensic Medicine (139 citations) and Cancer Research (99 citations). C. Barbara has collaborated with scholars based in Italy, Switzerland and United Kingdom. Frequent co-authors include Alfredo Falcone, Giacomo Allegrini, Gianluca Masi, Cristina Granetto, Lucio Crinò, I. Brunetti, M. Andreuccetti, S. Vitello, Silvana Chiara and W. Evangelista. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Therapeutic Drug Monitoring, Journal of the European Academy of Dermatology and Venereology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact